eQTLs and sQTLs that are associated with expression of these candidate genes may be used in building polygenic risk prediction models to assess ER + and ER- breast cancer risk separately and to guide risk-adaptive breast cancer screening. This evidence concerns the gene ESR1 and breast cancer.